Investment adviser · CRD 314372

4BIO PARTNERS LLP

Exempt reporting adviser (ERA)

Exempt reporting advisers use a shorter Form ADV report. Some adviser-level figures are not reported; fund disclosures appear below when available.

LONDON, United Kingdom · Form ADV filed Jul 15, 2026

Adviser-level assets, account counts and staffing figures are unavailable in this filing. View the reported fund disclosures below →

Private funds & service providers

3 Private funds

The count excludes feeder funds. Funds in the latest filing appear first, ordered by reported gross assets. Earlier funds retain their last reported values.

4BIO VENTURES III LPPrivate Equity Fund · Last reported Jul 15, 2026$154MGross asset value
Fund administrator APEX FUND AND CORPORATE SERVICES (UK) LIMITED LONDON, United Kingdom Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor BLICK ROTHENBERG LONDON, United Kingdom
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
Yes
External marketing
No
Fund details & source
Fund ID
805-5697093456
Reported beneficial owners
55
Minimum commitment
$5M

Form ADV 2116918 · Jul 15, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

4BIO VENTURES II LPPrivate Equity Fund · Last reported Jul 15, 2026$110MGross asset value
Fund administrator 4BIO PARTNERS LLP LONDON, United Kingdom Investor statements: Yes (provided to all investors) Related to adviser: Yes
Auditor BLICK ROTHENBERG LONDON, United Kingdom
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
Yes
External marketing
No
Fund details & source
Fund ID
805-9718979095
Reported beneficial owners
60
Minimum commitment
$5M

Form ADV 2116918 · Jul 15, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

4BIO ADVANCED THERAPIES FUND ICAVLiquidity Fund · Last reported Dec 2, 2025$440KGross asset value

Feeder funds

  • 4BIO ADVANCED THERAPIES LONG EQUITY FUND
Fund administrator SOCIETE GENERALE SA (IRELAND) DUBLIN, Ireland Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor EISNERAMPER DUBLIN, Ireland
Custodian SOCIETE GENERALE SA (IRELAND) DUBLIN, Ireland Related to adviser: No
Prime broker SOCIETE GENERALE SA (IRELAND) DUBLIN, Ireland
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No
Fund details & source
Fund ID
805-9220847822
Reported beneficial owners
1
Minimum commitment
$200K

Form ADV 2027418 · Dec 2, 2025 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Services & filing details

Most recent filing: Jul 15, 2026. View historical filings

Reported services

Not reported in these imported fields

Compensation

Not reported in these imported fields

Principal office

20 NORTH AUDLEY STREET
LONDON, W1K 6WE, United Kingdom

CRD 314372

Filing source

Form ADV 2116918 · Jul 15, 2026 · Items 1 & 5

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.